TP53 and cancer: In hrHPV+ PSCC, loss of p53 may also prolong NF-κB activation and consequently change the secretome of HPV+ cancer cells, inducing the chemokine-dependent recruitment of macrophages and/or polarization of macrophages toward a tumor-promoting CD68+CD163+ M2 phenotype.